Skip to main content
. 2020 Feb 15;12(2):478–492.

Figure 1.

Figure 1

FASSs promoted HUVEC proliferation and migration in a dose-dependent manner. A. CCK-8 assay for evaluating HUVEC viability. B. FASSs augmented HUVEC proliferation as determined using a hemocytometer. C, D. Scratch assay and Transwell assay on HUVECs. FASSs showed notable increased migratory capacity in a dose-dependent manner compared to the control group. *P<0.05, **P<0.01.